Company profile
QHSLab, Inc.
OTC: USAQ · Healthcare · Medical - Devices
#767 of 1,418 Healthcare companies by revenue70th-percentile growth
EA Score
70BFH 87DQ 59GM 53SS 43
v0.1 · 65/100 weight · provisional
↑ return on assets, return on equity · ↓ growth stability, workforce scale
Methodology →Revenue TTM
$2.8M
Rev growth YoY (TTM)
+21.2%
Net income (FY)
$457.4k
Employees
12
as of 2026-08-24
Market cap
$4.5M
as of 2026-08-24
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.7M$2.7M2025
Net income$457.4k$457.4k2025
Operating income$131.2k$131.2k2025
Total assets$2.2M$2.2M2025
Liabilities$546.1k$546.1k2025
Equity$1.6M$1.6M2025
Revenue trend
FY2014 – FY2025 · USD
FY14
FY15
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Subscription Revenue51%
Shipping and Handling49%
By geography
Not disclosed.
The read
What is QHSLab, Inc.’s revenue?
QHSLab, Inc. booked $2.7M in FY2025 revenue, growing 26% year over year — faster than most Healthcare companies we track, at a 17.0% net margin.
Peers · Healthcare
RxElite, Inc.——Absci Corporation47DHypha Labs, Inc.35DInnovative Eyewear, Inc.45DInfinity Pharmaceuticals, Inc.——ENvue Medical, Inc.46DNeighbors
Palm Beach →Key facts
CEOTroy James Grogan
SectorHealthcare
IndustryMedical - Devices
HeadquartersWest Palm Beach, FL
ExchangeOTC: USAQ
Employees12
IPO date2013-05-22
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.